Cargando…

Non-cultured melanocyte transfer in the management of stable vitiligo

BACKGROUND AND AIMS: Present study aimed to determine the clinical outcome for non-cultured melanocyte transfer in the management of stable vitiligo. METHODS: A hospital based prospective study was conducted including 50 stable unresponsive patients of vitiligo undergoing non-cultured melanocyte tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Birinder Singh, Brar, Manmohan Singh, Chaudhary, Neha, Randhawa, Avneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820390/
https://www.ncbi.nlm.nih.gov/pubmed/31681666
http://dx.doi.org/10.4103/jfmpc.jfmpc_546_19
_version_ 1783463928139874304
author Gill, Birinder Singh
Brar, Manmohan Singh
Chaudhary, Neha
Randhawa, Avneet
author_facet Gill, Birinder Singh
Brar, Manmohan Singh
Chaudhary, Neha
Randhawa, Avneet
author_sort Gill, Birinder Singh
collection PubMed
description BACKGROUND AND AIMS: Present study aimed to determine the clinical outcome for non-cultured melanocyte transfer in the management of stable vitiligo. METHODS: A hospital based prospective study was conducted including 50 stable unresponsive patients of vitiligo undergoing non-cultured melanocyte transplant. Re-pigmentation was analyzed on the basis of baseline photographs after 6 months post procedure. Degree of re-pigmentation was estimated to the nearest of one of the following percentages and the final outcome of re-pigmentation for statistical analysis was graded as: >70% re-pigmentation: Good; 30-69% re-pigmentation: Fair and; <30% re-pigmentation: Poor. RESULTS: The mean age of study group was 29.79 ± 13.8 with 52% males and 48% females. Out of total 50 patients, 31 (62%) patients showed good re-pigmentation, 10 (20%) showed fair re-pigmentation while 9 (18%) patients showed poor re-pigmentation. Patches over face, lips, trunk and legs showed good re-pigmentation, however patches over acral areas and bony prominences had poor re-pigmentation. CONCLUSION: Autologous non-cultured melanocyte transfer have an edge over the other modalities, however, proper patient selection, proper technique and good laboratory set up is required. It has an advantage over conventional split skin thickness grafting as it requires very little donor site skin.
format Online
Article
Text
id pubmed-6820390
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-68203902019-11-01 Non-cultured melanocyte transfer in the management of stable vitiligo Gill, Birinder Singh Brar, Manmohan Singh Chaudhary, Neha Randhawa, Avneet J Family Med Prim Care Original Article BACKGROUND AND AIMS: Present study aimed to determine the clinical outcome for non-cultured melanocyte transfer in the management of stable vitiligo. METHODS: A hospital based prospective study was conducted including 50 stable unresponsive patients of vitiligo undergoing non-cultured melanocyte transplant. Re-pigmentation was analyzed on the basis of baseline photographs after 6 months post procedure. Degree of re-pigmentation was estimated to the nearest of one of the following percentages and the final outcome of re-pigmentation for statistical analysis was graded as: >70% re-pigmentation: Good; 30-69% re-pigmentation: Fair and; <30% re-pigmentation: Poor. RESULTS: The mean age of study group was 29.79 ± 13.8 with 52% males and 48% females. Out of total 50 patients, 31 (62%) patients showed good re-pigmentation, 10 (20%) showed fair re-pigmentation while 9 (18%) patients showed poor re-pigmentation. Patches over face, lips, trunk and legs showed good re-pigmentation, however patches over acral areas and bony prominences had poor re-pigmentation. CONCLUSION: Autologous non-cultured melanocyte transfer have an edge over the other modalities, however, proper patient selection, proper technique and good laboratory set up is required. It has an advantage over conventional split skin thickness grafting as it requires very little donor site skin. Wolters Kluwer - Medknow 2019-09-30 /pmc/articles/PMC6820390/ /pubmed/31681666 http://dx.doi.org/10.4103/jfmpc.jfmpc_546_19 Text en Copyright: © 2019 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Gill, Birinder Singh
Brar, Manmohan Singh
Chaudhary, Neha
Randhawa, Avneet
Non-cultured melanocyte transfer in the management of stable vitiligo
title Non-cultured melanocyte transfer in the management of stable vitiligo
title_full Non-cultured melanocyte transfer in the management of stable vitiligo
title_fullStr Non-cultured melanocyte transfer in the management of stable vitiligo
title_full_unstemmed Non-cultured melanocyte transfer in the management of stable vitiligo
title_short Non-cultured melanocyte transfer in the management of stable vitiligo
title_sort non-cultured melanocyte transfer in the management of stable vitiligo
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820390/
https://www.ncbi.nlm.nih.gov/pubmed/31681666
http://dx.doi.org/10.4103/jfmpc.jfmpc_546_19
work_keys_str_mv AT gillbirindersingh nonculturedmelanocytetransferinthemanagementofstablevitiligo
AT brarmanmohansingh nonculturedmelanocytetransferinthemanagementofstablevitiligo
AT chaudharyneha nonculturedmelanocytetransferinthemanagementofstablevitiligo
AT randhawaavneet nonculturedmelanocytetransferinthemanagementofstablevitiligo